October 2017

A FILM about medicinal cannabis to help New Zealanders and doctors better understand the science, regulatory and health aspects is showing in a special screening at the Dome tomorrow evening. The 30-minute documentary film Mum, Cannabis, and Me – The Right To Informed Choice, by the University of Otago’s Victoria Catherwood, challenges the laws and […]

by

A FILM about medicinal cannabis to help New Zealanders and doctors better understand the science, regulatory and health aspects is showing in a special screening at the Dome tomorrow evening. The 30-minute documentary film Mum, Cannabis, and Me – The Right To Informed Choice, by the University of Otago’s Victoria Catherwood, challenges the laws and […]

by

Twenty-nine states, the district, and the U.S. territories of Guam and Puerto Rico have legalized marijuana growth and use for medical reasons, while 17 other states have laws allowing limited use of cannabidiol, or CBD, the non-psychoactive ingredient in pot that holds promise for therapeutic use.  … read more at: https://www.huffingtonpost.com/entry/marijuana-legalization-gallup-poll_us_59f0c088e4b0d094a5b6b1ce

by

MATERIAL RECEIVED IN AUSTRALIA, PRE-CLINICAL TRIAL WORK COMMENCING Supply agreement part of Aphria’s global expansion strategy. Medical cannabis to be used in first of its kind global clinical trial targeting pain management in advanced cancer pain patients LEAMINGTON, ON, Oct. 24, 2017 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH or USOTCQB: APHQF), […]

by

LAST YEAR DEDI MEIRI, a cannabis researcher at the Technion, Israel’s oldest university, received a “before and after” video of an autistic boy. The before showed the boy helmeted, hands tied behind his back, butting his head against a wall. The after showed him calmly sitting at a table, sketching. The difference: two drops of […]

by

MATERIAL RECEIVED IN AUSTRALIA, PRE-CLINICAL TRIAL WORK COMMENCING Supply agreement part of Aphria’s global expansion strategy. Medical cannabis to be used in first of its kind global clinical trial targeting pain management in advanced cancer pain patients LEAMINGTON, ON, Oct. 24, 2017 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH or USOTCQB: APHQF), […]

by

SAN DIEGO, Oct. 20, 2017 (GLOBE NEWSWIRE) — Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead molecule, EHP-101, for the treatment of systemic scleroderma. This chronic autoimmune disease causes severe fibrosis of […]

by

SAN DIEGO, Oct. 20, 2017 (GLOBE NEWSWIRE) — Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead molecule, EHP-101, for the treatment of systemic scleroderma. This chronic autoimmune disease causes severe fibrosis of […]

by

TORONTO, ONTARIO — (Marketwired) — 10/19/17 — Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals sectors, today announced its results for the fiscal year ended June 30, 2017. […]

by

The new-drug pipeline is bursting with innovative treatments in clinical trials while the industry is growing by leaps and bounds. Many biotech stocks are catching the attention of Wall Street as new milestones and major developments are being achieved at a faster pace. The pipeline of new drugs of all kinds has exploded. According to […]

by